There is also a relevant role of resistin, an immunoinflammatory cytokine in charge of reducing phosphorylations of IRs in their interaction with insulin, by increasing the expression of TNF-α and IL-6, which leads to insulin-resistance and a proinflammatory process, ultimately blocking glucose translocation and promoting a hyperglycemic state. The gene discussed is RETN; the disease is Insulin resistance.